Your browser is no longer supported. Please, upgrade your browser.
Settings
KURA Kura Oncology, Inc. daily Stock Chart
KURA [NASD]
Kura Oncology, Inc.
Index- P/E- EPS (ttm)-1.63 Insider Own11.50% Shs Outstand37.30M Perf Week-1.59%
Market Cap715.04M Forward P/E- EPS next Y-2.05 Insider Trans- Shs Float24.89M Perf Month21.25%
Income-59.80M PEG- EPS next Q-0.43 Inst Own83.30% Short Float8.65% Perf Quarter24.80%
Sales- P/S- EPS this Y-12.60% Inst Trans-0.65% Short Ratio8.03 Perf Half Y47.46%
Book/sh3.92 P/B4.89 EPS next Y-15.80% ROA-35.50% Target Price27.71 Perf Year3.06%
Cash/sh4.44 P/C4.32 EPS next 5Y- ROE-40.00% 52W Range10.20 - 22.00 Perf YTD36.54%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-12.86% Beta2.48
Dividend %- Quick Ratio13.80 Sales past 5Y- Gross Margin- 52W Low87.94% ATR0.92
Employees43 Current Ratio13.80 Sales Q/Q- Oper. Margin- RSI (14)64.95 Volatility5.78% 5.22%
OptionableYes Debt/Eq0.00 EPS Q/Q20.40% Profit Margin- Rel Volume2.13 Prev Close19.39
ShortableYes LT Debt/Eq0.05 EarningsAug 06 AMC Payout- Avg Volume268.30K Price19.17
Recom1.50 SMA2010.08% SMA5017.38% SMA20026.11% Volume558,105 Change-1.13%
Nov-09-18Initiated Piper Jaffray Overweight
Aug-01-18Initiated H.C. Wainwright Buy $31
Oct-13-16Resumed Leerink Partners Outperform $15
Jan-22-16Initiated JMP Securities Mkt Outperform
Dec-30-15Initiated Oppenheimer Outperform $16
Dec-16-15Initiated Citigroup Buy
Jun-23-19 08:50AM  Do Insiders Own Shares In Kura Oncology, Inc. (NASDAQ:KURA)? Simply Wall St.
08:48AM  What Kind Of Investor Owns Most Of Kura Oncology, Inc. (NASDAQ:KURA)? Simply Wall St.
Jun-21-19 04:30PM  Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Jun-18-19 11:31PM  Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock GlobeNewswire
04:01PM  Kura Oncology Announces Commencement of Public Offering of Common Stock GlobeNewswire
10:46AM  Is Kura Oncology, Inc. (KURA) A Good Stock To Buy? Insider Monkey
Jun-17-19 09:31AM  Company News For Jun 17, 2019 Zacks
Jun-14-19 10:03AM  Kura Oncology Soars After Lymphoma Treatment Test Results TheStreet.com
07:48AM  Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal MarketWatch
07:00AM  Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma GlobeNewswire
May-15-19 12:14PM  Edited Transcript of KURA earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-09-19 01:15PM  Heres What Hedge Funds Think About Kura Oncology, Inc. (KURA) Insider Monkey
May-07-19 08:49PM  Kura Oncology, Inc. (KURA) Q1 2019 Earnings Call Transcript Motley Fool
05:54PM  Kura Oncology: 1Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports First Quarter 2019 Financial Results and Highlights Upcoming Milestones GlobeNewswire
Apr-30-19 07:30AM  Kura Oncology to Report First Quarter 2019 Financial Results GlobeNewswire
Apr-25-19 12:36PM  Edited Transcript of KURA earnings conference call or presentation 5-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Apr-02-19 04:04PM  Kura Oncology Identifies Farnesylated Proteins Associated with CXCL12 Expression, Potential Biomarker of Clinical Benefit from Tipifarnib in Lymphoma Indications GlobeNewswire
Mar-29-19 07:10AM  Detailed Research: Economic Perspectives on Five Below, INVESCO MORTGAGE CAPITAL INC, Amicus Therapeutics, Akamai Technologies, Kura Oncology, and Columbus McKinnon What Drives Growth in Today's Competitive Landscape GlobeNewswire
Mar-27-19 07:16AM  The Kura Oncology (NASDAQ:KURA) Share Price Has Soared 317%, Delighting Many Shareholders Simply Wall St.
Mar-06-19 07:30AM  Kura Oncology to Participate in Two Upcoming Investor Conferences GlobeNewswire -7.29%
Mar-05-19 07:13PM  Kura Oncology, Inc. (KURA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:03PM  Kura Oncology Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
07:30AM  Kura Oncology Announces FDA Clearance of Investigational New Drug Application for Menin-MLL Inhibitor KO-539 GlobeNewswire
Feb-26-19 07:30AM  Kura Oncology to Report Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-20-19 07:30AM  Kura Oncology to Present at SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-19-19 07:40AM  Detailed Research: Economic Perspectives on Tesla, Kura Oncology, ASML Holding N.V, Applied Industrial Technologies, Raven Industries, and Intra-Cellular Therapies What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-18-19 10:00AM  Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression GlobeNewswire
Jan-03-19 07:30AM  Kura Oncology to Present at J.P. Morgan Healthcare Conference GlobeNewswire
Dec-15-18 11:21PM  Kura Oncology, Inc. (KURA): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-03-18 09:19AM  Edited Transcript of KURA earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +10.63%
Dec-02-18 12:00PM  Kura Oncology Announces Proof of Concept in Angioimmunoblastic T-Cell Lymphoma, Validation of CXCL12 as a Therapeutic Target of Tipifarnib in Peripheral T-Cell Lymphoma GlobeNewswire
Nov-30-18 07:50AM  Report: Exploring Fundamental Drivers Behind J.B. Hunt Transport Services, Kura Oncology, National Beverage, Benefitfocus, PTC Therapeutics, and Walgreens Boots Alliance New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-28-18 07:30AM  Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma GlobeNewswire +6.48%
Nov-08-18 07:30AM  Kura Oncology Adds Commercial Veteran Mary Szela to Board of Directors GlobeNewswire
Nov-06-18 07:30AM  Kura Oncology to Participate in Two Upcoming Investor Conferences GlobeNewswire
Nov-05-18 06:14PM  Kura Oncology: 3Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
07:30AM  Kura Oncology Initiates Registration-Directed Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinomas GlobeNewswire
Nov-01-18 09:00AM  Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting GlobeNewswire
Oct-29-18 07:30AM  Kura Oncology to Report Third Quarter 2018 Financial Results GlobeNewswire
Oct-25-18 08:53AM  3 Beaten-Down Biotech Stocks: Can They Bounce Back? Motley Fool +5.75%
Oct-23-18 09:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Dropbox, Kura Oncology, DHT, Wayfair, US Foods Holding, and InflaRx N.V New Research Emphasizes Economic Growth GlobeNewswire
Oct-22-18 02:20PM  Here's Why Kura Oncology Fell Today Motley Fool -18.85%
08:45AM  Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC GlobeNewswire
Sep-26-18 04:05PM  Kura Oncology to Present at Leerink Partners Rare Disease & Oncology Roundtable GlobeNewswire
Aug-30-18 07:30AM  Kura Oncology to Present at H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-20-18 11:45AM  Edited Transcript of KURA earnings conference call or presentation 6-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 04:05PM  Kura Oncology to Present at 2018 Wedbush PacGrow Healthcare Conference GlobeNewswire -12.29%
Aug-06-18 04:36PM  Kura Oncology: 2Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Kura Oncology, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 07:30AM  Kura Oncology Appoints Marc Grasso, M.D., as Chief Financial Officer and Chief Business Officer GlobeNewswire
Jul-30-18 04:05PM  Kura Oncology to Report Second Quarter 2018 Financial Results GlobeNewswire
Jul-02-18 04:30PM  Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Jun-28-18 07:30AM  Kura Oncology Announces Pricing of $67 Million Public Offering of Common Stock GlobeNewswire
Jun-27-18 04:01PM  Kura Oncology Announces Commencement of Public Offering of Common Stock GlobeNewswire
Jun-20-18 07:30AM  Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial GlobeNewswire
Jun-14-18 07:30AM  Kura Oncology to Present at JMP Securities Life Sciences Conference GlobeNewswire
May-22-18 07:00AM  OncoDNA announces screening collaboration with Kura Oncology GlobeNewswire
May-14-18 07:51PM  Edited Transcript of KURA earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-08-18 07:14PM  Kura Oncology: 1Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-03-18 07:30AM  Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference GlobeNewswire
May-02-18 07:30AM  Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies GlobeNewswire
May-01-18 07:30AM  Kura Oncology to Report First Quarter 2018 Financial Results GlobeNewswire
Apr-09-18 07:30AM  Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018 GlobeNewswire
Mar-28-18 08:08PM  What You Must Know About Kura Oncology Incs (NASDAQ:KURA) Market Risks Simply Wall St.
03:11PM  Edited Transcript of KURA earnings conference call or presentation 7-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
12:03PM  Edited Transcript of KURA earnings conference call or presentation 15-May-17 8:30pm GMT Thomson Reuters StreetEvents
Mar-26-18 08:04PM  Edited Transcript of KURA earnings conference call or presentation 12-Mar-18 8:30pm GMT Thomson Reuters StreetEvents +5.15%
Mar-16-18 07:30AM  Kura Oncology to Present at Oppenheimer 28th Annual Healthcare Conference GlobeNewswire
Mar-13-18 08:20AM  Todays Research Reports on Trending Tickers: Kura Oncology and Zynerba Pharmaceuticals ACCESSWIRE
Mar-12-18 05:17PM  Kura Oncology reports 4Q loss Associated Press
04:05PM  Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
01:15PM  Kura Oncology, Inc. to Host Earnings Call ACCESSWIRE
07:34AM  Kura Oncology Inc (NASDAQ:KURA): Is Breakeven Near? Simply Wall St.
Mar-06-18 07:30AM  Kura Oncology to Present at Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-05-18 04:05PM  Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Feb-19-18 04:41PM  Who Are The Major Shareholders Of Kura Oncology Inc (NASDAQ:KURA)? Simply Wall St.
Feb-15-18 11:00AM  Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer GlobeNewswire +11.67%
Feb-08-18 07:30AM  Kura Oncology to Present at the Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire
Jan-03-18 12:28PM  Does Kura Oncology Incs (NASDAQ:KURA) CEO Pay Reflect Performance? Simply Wall St.
Dec-26-17 05:35PM  All You Need To Know About Kura Oncology Incs (NASDAQ:KURA) Risks Simply Wall St.
Dec-21-17 03:26PM  Wedbush Rates Kura Oncology Outperform As Catalysts Loom Benzinga +6.64%
Dec-18-17 07:30AM  Kura Oncology Added to Nasdaq Biotechnology Index GlobeNewswire
Dec-12-17 02:34PM  What Is The Future Prospect For Healthcare And Kura Oncology Inc (undefined:KURA)? Simply Wall St.
Dec-11-17 10:00AM  Kura Oncology Identifies Potential Biomarkers of Activity for Lead Candidate Tipifarnib in Bone Marrow Cancers GlobeNewswire -7.05%
Dec-10-17 09:00AM  Kura Oncology Reports Positive Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia GlobeNewswire
Nov-09-17 04:05PM  Kura Oncology to Host Investor Day on November 16, 2017 GlobeNewswire +9.03%
Nov-07-17 05:59PM  Kura Oncology reports 3Q loss Associated Press -5.41%
04:05PM  Kura Oncology Reports Third Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
12:00PM  Kura Oncology, Inc. to Host Earnings Call ACCESSWIRE
Nov-01-17 04:05PM  Kura Oncology Announces Upcoming Presentations at American Society of Hematology Annual Meeting GlobeNewswire
Oct-31-17 04:05PM  Kura Oncology to Report Third Quarter 2017 Financial Results GlobeNewswire
Oct-28-17 12:30PM  Kura Oncology Development Candidate KO-539 Shows Robust Preclinical Anti-Tumor Activity in NPM1- and DNMT3A-Mutant AML GlobeNewswire
Oct-27-17 10:50AM  Kura Oncology Lead Candidate Tipifarnib Shows Durable Anti-Tumor Activity in HRAS Mutant Head and Neck Cancer in AACR-NCI-EORTC Update GlobeNewswire
Oct-16-17 07:30AM  Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer and for KO-539 in AML at Upcoming AACR-NCI-EORTC International Conference GlobeNewswire
Sep-21-17 10:56AM  Zacks.com featured highlights include Build-A-Bear Workshop, Kura Oncology, Norsk Hydro, Schnitzer Steel Industries and SYNNEX Zacks
Sep-20-17 03:57PM  Is It Time To Buy Kura Oncology Inc (KURA)? Simply Wall St.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidate is Tipifarnib, an oral farnesyl transferase inhibitor that is in Phase II clinical trials for the treatment of solid tumors, peripheral T-cell lymphomas, myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia. It is also developing KO-947, a small molecule inhibitor of extracellular signal related kinase used for the treatment of patients with tumors that have dysregulated activity due to mutations or other mechanisms in the mitogen-activated protein kinase pathway; and KO-539, a small molecule inhibitor of the menin-mixed lineage leukemia protein-protein interaction. The company was founded in 2014 and is headquartered in San Diego, California.